Global platform brings holistic, preventive, and integrative wellness journeys to consumers worldwide The future of ...

Growth is driven by rising chronic disease prevalence, aging populations, and increasing consumer preference for natural, non ...

Complementary therapies are often used to help address symptoms of chronic health conditions and improve overall well-being. But finding a qualified provider is essential to reap the benefits — here ...

Men with prostate cancer are reported as commonly using complementary and alternative medicine (CAM) but surveys have not recently been subjected to a rigorous systematic review incorporating quality ...

A new federal report reveals that Americans spend about $30 billion a year on complementary health approaches, from ginkgo biloba to yoga. Complementary medical approaches are alternative types of ...

With the increased interest in complementary therapies, a team of scientists recently explored their use in cancer patients, and how they impacted both adherence to treatments and survival rates.

Complementary and alternative medicines are all over lately: herbal supplements, massage, essential oils, and more. You might love how some of these therapies make you feel, but are they safe for your ...

Integrative medicine (IM) is an approach that combines conventional medicine with complementary treatments. The aim of IM is to treat the whole person, not just a health problem. Because IM is ...

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, ...

What is complementary and alternative medicine? Complementary and alternative medicine includes a wide range of healing practices that some people use to treat lupus or other conditions. Some examples ...

Ken Harvey has represented Choice (the Australian Consumers’ Association) on TGA consultations about regulatory reform of complementary medicines. He is also an executive member of Friends of Science ...

Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study Of 432 patients surveyed, 66.9% were ...